Substantial and Increasing Burden of Skin Cancer Seen in Older Adults
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, May 30, 2025 -- Older adults have a substantial and increasing burden of skin cancer, according to a study published online May 21 in JAMA Dermatology.
Ruiyao Wang, M.D., from The First Affiliated Hospital of Chongqing Medical University in China, and colleagues examined the global burden of skin cancer among adults aged 65 years or older from 1990 to 2021, and projected change to 2050 in a study using data from the Global Burden of Diseases Study 2021, which covers 204 countries and territories.
The researchers estimated 153,993 melanoma, 1,463,424 squamous cell carcinoma (SCC), and 2,802,354 basal cell carcinoma (BCC) instances worldwide for 2021. The highest age-standardized rate of prevalence, deaths, and disability-adjusted life-years (DALYs) were seen for SCC (236.91, 6.16, and 95.50 per 100,000 population, respectively), while the highest incidence rate was seen for BCC (371.97 per 100,000). Compared with females, the disease burden was notably greater in males. A general upward trend was seen for the global burden of skin cancer among older people during the observation period. The primary contributor to this increase was population growth. A disproportionately higher burden was shouldered by countries with higher sociodemographic index levels. By 2050, only incidence and prevalence rates attributable to keratinocyte cancer, along with the DALYs rate related to BCC, would increase.
"Our results underscore the urgency to enact prevention and treatment strategies tailored to high-risk older populations," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-31 00:00
Read more

- Recovering From A Heart Attack? Here's What You Shouldn't Do
- Nicotine Pouch Use Doubles Among U.S. High Schoolers
- Dementia Tied To Heart, Metabolic Diseases
- FDA Approves Nucala for Chronic Obstructive Pulmonary Disease
- Colorado Reporting New Outbreak of Measles
- Socioeconomic Status Tied to New Diagnosis of Hidradenitis Suppurativa
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions